Selim Gök

Comparison of efficacy and toxicity of treosulfan-fludarabine and busulfan-cyclophosphamide conditioning regimens in patients undergoing allogeneic stem cell transplantation

M. Erkurt, İ. Berber, A. Sarici, 2021, Medicine Science | International Medical Journal.

The effect of comorbidity on survival and collected CD34 + cell counts in autologous hematopoietic stem cell transplant patients.

M. Erkurt, İ. Berber, A. Sarici, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience.

M. Erkurt, İ. Berber, A. Sarici, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

FLAMSA vs BU-FLU in patients undergoing allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome

M. Erkurt, İ. Berber, A. Sarici, 2021 .

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?

A. Sarici, Ömer Faruk Bahçecíoğlu, Selim Gök, 2021, Hematology, transfusion and cell therapy.

Monoamineoxidase-B (MAO-B) Inhibitors in theTreatment of Alzheimer's and Parkinson's Disease.

M. Alagöz, Z. Özdemir, Ömer Faruk Bahçecíoğlu, 2021, Current medicinal chemistry.

Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients.

M. Erkurt, İ. Berber, A. Sarici, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Daptomycin in combination with rosuvastatin induced blood creatine phosphokinase elevation

Ömer Faruk Bahçecíoğlu, Selim Gök, M. Durmuş, 2020, European journal of hospital pharmacy : science and practice.

Is sitagliptin effective for the treatment of COVID-19?

A. Cakir, Ömer Faruk Bahçecíoğlu, Selim Gök, 2021, European journal of hospital pharmacy : science and practice.